Brain Imaging and Analysis Center (BIAC)
Faculty members in the BIAC are leaders in imaging methodology development, analysis techniques, as well as in their application in cognitive and clinical neurosciences. In addition, BIAC offers imaging services to other faculty members on campus and at the University of North Carolina in Chapel Hill.
Center for Genomic & Computational Biology (GCB)
The mission of the GCB is to foster excellence in genomics and computational biology across Duke’s campus through research collaborations, educational activities, and core facilities. GCB faculty members are passionate about interdisciplinary research that dissolves the distinction between the wet lab and quantitative analysis. GCB educational programs support undergraduates, graduate students, and senior researchers with a variety of classes, hands-on workshops, and research opportunities. The GCB operate six core facilities that provide expertise and services in genomic and computational technologies and in data analysis.
Center for the Study of Aging and Human Development
One of five centers for aging research established by the surgeon general of the United States in 1955, the center is the only continuously funded member of the original group. With more than 126 faculty members (senior fellows) and core staff members and more than $20 million in annual age-related research funding, it remains a vital national resource for the study of aging.
Duke Cancer Institute (DCI)
By uniting hundreds of cancer physicians, researchers, educators, and staff across the medical center, medical school, and health system under a shared administrative structure, the DCI offers unprecedented opportunities for teamwork among laboratory scientists and health care providers caregivers in Duke hospitals and clinics.
Duke Clinical and Translational Science Institute (CTSI)
The Clinical & Translational Science Institute is the administrative home for the Duke Clinical and Translational Science Award (CTSA) and will oversee and integrate CTSA core services into the fabric of translational science at Duke. It will focus on leveraging the vast research resources at Duke University and facilitating collaborations that provide or enhance the infrastructure, education, and resources needed to take promising ideas from concept, through development and testing, and into patient care.
Duke Clinical Research Institute (DCRI)
The world's largest academic clinical research organization, the DCRI is known for conducting groundbreaking multi-national clinical trials, managing major national patient registries, and performing landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics.
The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.
Duke Forge is Duke University’s new center for health data science. Located within the School of Medicine, the center unites experts from across the campus with interest and expertise in data science. Faculty, staff, and students create innovative approaches to fuse biostatistics and machine learning and implement insights gained into improving patient care and leveraging digital information to enable healthy living and disease prevention.
Duke Forge is led by Robert M. Califf, MD, vice chancellor for health data science and former FDA commissioner.
Duke Global Health Institute (DGHI)
Faculty members in the DGHI work to reduce health disparities in the local community and worldwide. The DGHI recognizes that many global health problems stem from economic, social, environmental, political and health care inequalities, and the institute brings together interdisciplinary teams to solve complex health problems and to train the next generation of global health scholars.
Duke Human Vaccine Institute (DHVI)
The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases. The DHVI plays an integral leadership role in the Global HIV/AIDS Vaccine Enterprise and is a pioneer in emerging infections and biodefense research.
Duke Institute for Brain Sciences (DIBS)
The Duke Institute for Brain Sciences (DIBS) is a cross-school, campus-wide, interdisciplinary institute at Duke University with a commitment to building an interactive community of brain science research and scholarship. DIBS encourages innovation and collaboration that transcend the boundaries of traditional disciplines, bringing together a diverse community of academics from biomedical science, social science, physical science, humanities, law, business, public policy, mathematics, computer science and engineering.
Duke Institute for Health Innovation (DIHI)
The Duke Institute for Health Innovation (DIHI) promotes innovation in health and health care through high-impact innovation pilots, leadership development, and cultivation of a community of entrepreneurship. DIHI brings innovative solutions to the most pressing challenges in health and health care by catalyzing multidisciplinary teamwork across Duke University and Duke Medicine and by fostering collaborations with national and international thought leaders.
Duke Molecular Physiology Institute (DMPI)
The DMPI produces integrated multi-omics and physiologic profiles of chronic human diseases, and uses such profiles to develop new disease detection strategies, novel therapies, and insights into disease mechanisms.
The Marcus Center for Cellular Cures
The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine has been established to bring together physicians and faculty across medicine and engineering at Duke to develop cellular and biological therapies for autism, cerebral palsy, stroke, multiple sclerosis and related brain disorders.
Trent Center for Bioethics, Humanities and History of Medicine
The Trent Center is committed to the critical examination of ethical and social issues in the practice of medicine, the process of research and the distribution of resources to improve health.
School of Medicine Initiatives
MEDx (Medicine + Engineering at Duke) fosters the exchange of ideas and creates research opportunities between physicians, engineers, computer scientists, researchers and innovators. It promotes the training of the next generation of researchers and clinicians to work symbiotically on new solutions to complex clinical problems. And it works to develop strategic commercialization opportunities to translate research advances into effective devices, therapeutics and care delivery systems.
Regeneration Next is a Duke University School of Medicine initiative with the goals to advance discovery research and education in the broad field of tissue regeneration for faculty, trainees, and staff throughout the Duke University campus, and to enable translational applications for regenerative medicine.